5.8 million shares of Common Stock (par value $0.20 per share) GOODRICH PETROLEUM CORPORATION UNDERWRITING AGREEMENT December 4, 2007
Exhibit 1.1
EXECUTION COPY
5.8 million shares of
Common Stock
(par value $0.20 per share)
(par value $0.20 per share)
XXXXXXXX PETROLEUM CORPORATION
December 4, 2007
BEAR, XXXXXXX & CO. INC. (“Bear Xxxxxxx”),
as Lead Manager (as defined below),
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
as Lead Manager (as defined below),
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
BEAR, XXXXXXX & CO. INC,
in its capacity as an agent for one of its affiliates,
as Bear Hedge Seller (as defined below),
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
in its capacity as an agent for one of its affiliates,
as Bear Hedge Seller (as defined below),
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
X.X. XXXXXX SECURITIES INC. (“XX Xxxxxx”),
as Lead Manager (as defined below),
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
as Lead Manager (as defined below),
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
X.X. XXXXXX SECURITIES INC.,
in its capacity as an agent for one of its affiliates,
as JPM Hedge Seller (as defined below),
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
in its capacity as an agent for one of its affiliates,
as JPM Hedge Seller (as defined below),
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies/Gentlemen:
Xxxxxxxx Petroleum Corporation, a corporation organized and existing under the laws of
Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and
sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of
4,205,000 shares (the “Distribution Shares”) of Common Stock, $0.20 par value (the “Common Stock”)
of the Company and, for the sole purpose of covering over-allotments in
connection with the sale of the Distribution Shares, at the option of the Underwriters, up to
an aggregate of 630,750 Distribution Shares (the “Additional Distribution Shares”).
Concurrently with the issuance of the Distribution Shares, the Company and Bear Xxxxxxx,
acting as an agent for one of its affiliates, will execute a confirmation and a side letter
agreement and the Company and XX Xxxxxx, acting as an agent for one of its affiliates, will execute
a confirmation and a side letter agreement (collectively, the “Capped Call Agreements”) with
respect to certain options transactions and related matters described therein.
To allow Bear Xxxxxxx and XX Xxxxxx to hedge their (or their affiliates’) respective exposure
under the Capped Call Agreements, the Company proposes, subject to the terms and conditions stated
herein, to issue and sell an aggregate of 1,595,000 shares of Common Stock (the “Hedge Shares” and,
together with the Distribution Shares, the “Initial Shares”) of the Company to Bear Xxxxxxx (the
“Bear Hedge Seller”) and XX Xxxxxx (the “JPM Hedge Seller” and, together with the Bear Hedge
Seller, the “Hedge Sellers”), each acting as an agent for one of its respective affiliates. The
Initial Shares and any Additional Distribution Shares are referred to herein as the “Shares”.
Bear Xxxxxxx and XX Xxxxxx are acting as lead managers (the “Lead Managers”) in connection
with the offering and the sale of the Distribution Shares.
The offering and sale to the public of the Distribution Shares and, from time to time, the
Hedge Shares is herein referred to as the “Offering.”
The Company also proposes, subject to the terms of this agreement (this “Agreement”), the
applicable rules, regulations and interpretations of the FINRA (as defined below) and all other
applicable laws, rules and regulations, that 260,000 of the Distribution Shares (the “Directed
Shares”) shall be reserved for sale by the Underwriters to certain officers, directors, employees
and other persons designated by the Company (“Directed Share Purchasers”). To the extent that
sales of Directed Shares are not orally confirmed for purchase by Directed Share Purchasers by 8
a.m. (Eastern) on the first trading day after the date of this Agreement, the Directed Shares will
be offered to the public as part of the Offering.
1. Representations and Warranties of the Company. The Company represents and warrants
to, and agrees with, the Underwriters that:
(a) The Company has filed with the Securities and Exchange Commission (the “Commission”) a
registration statement under the Securities Act of 1933, as amended (the “Securities Act”), on Form
S-3 (No. 333-145339) (the initial filing and all pre-effective amendments thereto collectively
being referred to as the “Initial Registration Statement”); and such Initial Registration
Statement, and any post-effective amendment thereto, each in the form previously delivered to you,
have been declared effective by the Commission, in such form. Other than a registration statement,
if any, increasing the size of the Offering (a “Rule 462(b) Registration Statement”) filed pursuant
to Rule 462(b) under the Securities Act, which will become effective upon filing, no other document
with respect to the Initial Registration Statement has heretofore been filed with the Commission.
The various parts of the Initial Registration Statement and the 462(b) Registration Statement, if
any, including all exhibits
2
thereto and including (i) the information contained in the form of final prospectus filed with
the Commission pursuant to Rule 424(b) under the Securities Act in accordance with Section 4(a)
hereof and deemed by virtue of Rule 430A under the Securities Act to be part of the Initial
Registration Statement at the time it became effective under the Securities Act with respect to the
Underwriters, and (ii) the documents incorporated by reference in the prospectus contained in the
Initial Registration Statement at the time such part of the Initial Registration Statement becomes
effective, each as amended at the time such part of the Initial Registration Statement or Rule
462(b) Registration Statement, if any, became or hereafter becomes effective under the Securities
Act with respect to the Underwriters, are hereafter collectively referred to as the “Registration
Statement.” Any reference to any amendment to the Registration Statement shall be deemed to refer
to and include any annual report of the Company filed pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the effective date of the
Initial Registration Statement that is incorporated by reference therein. No stop order suspending
the effectiveness of the Initial Registration Statement, any post-effective amendment thereto or
the Rule 462(b) Registration Statement, if any, has been issued and no proceeding for that purpose
has been initiated or threatened by the Commission.
The prospectus supplement dated as of December 4, 2007, in the form in which it is to be filed
with the Commission pursuant to Rule 424(b) (the “Prospectus Supplement”), along with the base
prospectus included as part of the Registration Statement at the time the Registration Statement
became effective (the “Base Prospectus”), is hereinafter referred to as the “Prospectus,” except
that if any revised prospectus or prospectus supplement shall be provided to the Underwriters by
the Company for use in connection with the Offering which differs from the Prospectus (whether or
not such revised prospectus or prospectus supplement is required to be filed by the Company
pursuant to Rule 424(b)), the term “Prospectus” shall also refer to such revised prospectus or
prospectus supplement, as the case may be, from and after the time it is first provided to the
Underwriters for such use. Any preliminary prospectus supplement or supplements to the Base
Prospectus, together with the Base Prospectus, which describes the Shares and the Offering, is
hereafter called a “Preliminary Prospectus.” The Preliminary Prospectus relating to the Shares, as
amended or supplemented immediately prior to the Applicable Time (as defined below), is hereafter
referred to as the “Pricing Prospectus”. Any “issuer free writing prospectus” (as defined in Rule
433 under the Securities Act) relating to the Shares is hereafter referred to as an “Issuer Free
Writing Prospectus”; and the Pricing Prospectus, as supplemented by the number of Initial Shares,
Distribution Shares and Hedge Shares offered, the number of Additional Shares that the Underwriters
have an option to purchase, the public offering price of the Distribution Shares, the amount of the
net proceeds of the offering (estimated after the purchase of the capped call option and payment of
expenses) and the Issuer Free Writing Prospectuses, if any, attached and listed in Annex III
hereto, taken together, are hereafter referred to collectively as the “Pricing Disclosure Package”.
Any reference herein to the Preliminary Prospectus or the Prospectus shall be deemed to include
(x) any wrapper or supplement thereto prepared in connection with the distribution of Directed
Shares in any jurisdiction and (y) the documents incorporated by reference therein pursuant to Item
12 of Form S-3 which were filed under the Exchange Act on or before the date of such Preliminary
Prospectus or the date of the Prospectus, as the case may be. Any reference herein to any
“amendment” or “supplement” to any Preliminary Prospectus or the Prospectus shall be deemed to
refer to and include (i) the filing of any document under the Exchange Act after the
3
date of such Preliminary Prospectus or Prospectus, as the case may be, which is incorporated
therein by reference and (ii) any such document so filed.
The Company was not an “ineligible issuer” (as defined in Rule 405 under the Securities Act)
as of the eligibility determination date for purposes of Rules 164 and 433 under the Securities Act
with respect to the offering of the Shares contemplated hereby.
All references in this Agreement to the Registration Statement, any Preliminary Prospectus,
Issuer Free Writing Prospectus or the Prospectus, or any amendments or supplements to any of the
foregoing, shall be deemed to include any copy thereof filed with the Commission pursuant to its
Electronic Data Gathering, Analysis and Retrieval System (“XXXXX”).
(b) With respect to the Registration Statement, at the time of the effectiveness of the
Registration Statement or any Rule 462(b) Registration Statement or the effectiveness of any
post-effective amendment to the Registration Statement and with respect to the Prospectus, when the
Prospectus is first filed with the Commission pursuant to Rule 424(b) or Rule 434 under the
Securities Act (“Rule 434”), when any supplement to or amendment of the Prospectus is filed with
the Commission, at the Closing Date (as hereinafter defined), as of any Additional Closing Date (as
hereinafter defined) and at all times during the period beginning on the Closing Date and ending on
the earlier of (i) the day following the completion of the Offering or (ii) 60 Exchange Business
Days (as defined in the Capped Call Agreements) after the Closing Date (the “Offering Period”), the
Registration Statement complies and the Prospectus and any further amendments or supplements to the
Registration Statement or the Prospectus will comply in all material respects with the applicable
provisions of the Securities Act, the Exchange Act and the rules and regulations of the Commission
thereunder (the “Rules and Regulations”), and did not and will not, contain an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein (i) in the case of the Registration Statement, not misleading
and (ii) in the case of the Prospectus, in the light of the circumstances under which they were
made, not misleading; provided, however, that (x) this representation and warranty shall not apply
to any information contained in or omitted from the Registration Statement or the Prospectus or any
amendment thereof or supplement thereto in reliance upon and in conformity with information
furnished in writing to the Company by or on behalf of the Underwriters specifically for use
therein, and (y) subject to an extension of the Offering Period as set forth in Section 4(a)(ii)
hereof, the Offering Period will be deemed suspended for purposes of this Section 1(b), and this
representation shall not apply, from the time a notice is given by the Company pursuant to such
Section 4(a)(ii) until the amendment referred to in such Section 4(a)(ii) becomes effective (such
period, the “Suspension Period”). The parties hereto agree that such information provided by or on
behalf of the Underwriters consists solely of the material referred to in Section 16 hereof.
(c) No order preventing or suspending the use of any Preliminary Prospectus or any Issuer Free
Writing Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time
of filing thereof, complied in all material respects with the applicable provisions of the
Securities Act, the Exchange Act and the Rules and Regulations, and did not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that this representation and
4
warranty shall not apply to any information contained in or omitted from any Preliminary
Prospectus in reliance upon and in conformity with information furnished in writing to the Company
by or on behalf of the Underwriters specifically for use therein. The parties hereto agree that
such information provided by or on behalf of the Underwriters consists solely of the material
referred to in Section 16 hereof.
(d) For purposes of this Agreement, the “Applicable Time” is 4:00 p.m. (Eastern) on the date
of this Agreement. The Pricing Disclosure Package, as of the Applicable Time, did not, and as of
the Closing Date (as hereinafter defined), will not, contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Each Issuer
Free Writing Prospectus complies in all material respects with the applicable provisions of the
Securities Act and the Rules and Regulations, and does not include information that conflicts with
the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus,
and each Issuer Free Writing Prospectus not listed in Annex III hereto, as supplemented by and
taken together with the Pricing Disclosure Package, as of the Applicable Time, did not, and as of
the Closing Date will not, contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading. No representation and
warranty is made in this Section 1(d) with respect to any information contained in or omitted from
the Pricing Disclosure Package or any Issuer Free Writing Prospectus in reliance upon and in
conformity with information furnished in writing to the Company by or on behalf of the Underwriters
specifically for use therein. The parties hereto agree that such information provided by or on
behalf of the Underwriters consists solely of the material referred to in Section 16 hereof.
(e) KPMG LLP, who have certified the financial statements and supporting schedules and
information of the Company and its subsidiaries that are included or incorporated by reference in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, are independent
public accountants as required by the Securities Act, the Exchange Act and the Rules and
Regulations.
(f) Netherland Xxxxxx & Associates, Inc. (“Netherland Xxxxxx”), a petroleum engineering firm
from whose reserve reports information (the “Reserve Information”) is set forth in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, are independent petroleum engineers
with respect to the Company. Other than (i) the production of reserves in the ordinary course of
business (ii) intervening price fluctuations or (iii) as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, the Company is not aware of any facts or
circumstances that would result in a material adverse change in its proved reserves in the
aggregate, or the aggregate present value of estimated future net revenues of the Company or the
standardized measure of discounted future net cash flows therefrom, as described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus and reflected in the
Reserve Information as of the respective dates such information is given. Estimates of the proved
reserves and the present value of the estimated future net revenues and the discounted future net
cash flows derived therefrom as described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus and reflected in the Reserve
5
Information comply in all material respects to the applicable requirements of Regulation S-X
of the Securities Act Regulations and Industry Guide 2 under the Securities Act.
(g) Subsequent to the respective dates as of which information is given in the Registration
Statement and the Pricing Disclosure Package, except as disclosed in the Pricing Disclosure
Package, the Company has not declared, paid or made any dividends or other distributions of any
kind on or in respect of its capital stock and there has been no material adverse change or any
development involving a prospective material adverse change, whether or not arising from
transactions in the ordinary course of business, in the business, condition (financial or
otherwise), results of operations, stockholders’ equity, properties or prospects of the Company and
each subsidiary of the Company listed on Exhibit A hereto (the “Subsidiaries”), taken as a whole (a
“Material Adverse Change”). Since the date of the latest balance sheet included, or incorporated
by reference, in the Registration Statement and the Pricing Disclosure Package, neither the Company
nor any Subsidiary has incurred or undertaken any liabilities or obligations, whether direct or
indirect, liquidated or contingent, matured or unmatured, or entered into any transactions,
including any acquisition or disposition of any business or asset, which are material to the
Company and the Subsidiaries, individually or taken as a whole, except for liabilities, obligations
and transactions incurred in the ordinary course of business which are disclosed in the Pricing
Disclosure Package.
(h) The authorized, issued and outstanding capital stock of the Company is as set forth in the
Registration Statement, the Pricing Disclosure Package and the Prospectus under the caption
“Capitalization” (other than for subsequent issuances in the ordinary course of business, if any,
pursuant to employee benefit plans or upon exercise of outstanding options or conversion of
convertible securities described in the Pricing Disclosure Package) will be as set forth in the
column headed “As Adjusted” under the caption “Capitalization.” All of the issued and outstanding
shares of capital stock of the Company have been duly and validly authorized and issued, are fully
paid and non-assessable and were not issued in violation of or subject to any preemptive or similar
right that does or will entitle any person, upon the issuance or sale of any security, to acquire
from the Company or any Subsidiary any Common Stock or other security of the Company or any
security convertible into, or exercisable or exchangeable for, Common Stock or any other such
security (any “Relevant Security”), except for such rights as may have been fully satisfied or
waived prior to the effectiveness of the Registration Statement.
(i) The Shares have been duly and validly authorized and, when issued and delivered in
accordance with this Agreement, will be duly and validly issued, fully paid and non-assessable, and
will not have been issued in violation of or subject to any preemptive or similar right that
entitles any person to acquire any Relevant Security from the Company. The Common Stock and the
Shares conform to the descriptions thereof contained in the Registration Statement, the Pricing
Disclosure Package and the Prospectus. Except as disclosed in the Pricing Disclosure Package, the
Company has no outstanding warrants, options to purchase, or any preemptive rights or other rights
to subscribe for or to purchase, or any contracts or commitments to issue or sell, any Relevant
Security (other than for subsequent issuances in the ordinary course of business, if any, pursuant
to employee benefit plans). Except as disclosed in the Pricing Disclosure Package, no holder of
any Relevant Security has any rights to require registration under the Securities Act of any
Relevant Security in connection with the offer and sale of the Shares contemplated hereby.
6
(j) The Subsidiaries are the only “subsidiaries” of the Company within the meaning of Rule 405
under the Securities Act. Except for the Subsidiaries and as otherwise disclosed in the Pricing
Disclosure Package, the Company holds no ownership or other interest, nominal or beneficial, direct
or indirect, in any corporation, partnership, joint venture or other business entity. Xxxxxxxx
Petroleum Company LLC (the “Principal Subsidiary”) is the only Subsidiary that meets the definition
of “significant subsidiary” of the Company under the conditions specified in Rule 1-02(w)
Regulation S-X under the Securities Act. All of the issued shares of capital stock of or other
ownership interests in the Principal Subsidiary have been duly and validly authorized and issued
and are fully paid and non-assessable and are owned directly or indirectly by the Company free and
clear of any lien, charge, mortgage, pledge, security interest, claim, equity, trust or other
encumbrance, preferential arrangement, defect or restriction of any kind whatsoever (any “Lien”).
(k) Each of the Company and the Principal Subsidiary has been duly organized and validly
exists as a corporation, partnership or limited liability company in good standing under the laws
of its jurisdiction of organization. Each of the Company and the Subsidiaries is duly qualified to
do business and is in good standing as a foreign corporation, partnership or limited liability
company in each jurisdiction in which the character or location of its properties (owned, leased or
licensed) or the nature or conduct of its business makes such qualification necessary, except for
those failures to be so qualified or in good standing which (individually and in the aggregate)
could not reasonably be expected to have a material adverse effect on the business, condition
(financial or otherwise), results of operations, stockholders’ equity, properties or prospects of
the Company and the Subsidiaries, individually or taken as a whole (a “Material Adverse Effect”).
Each of the Company and the Principal Subsidiary has all requisite power and authority, and all
necessary consents, approvals, authorizations, orders, registrations, qualifications, licenses,
filings and permits of, with and from all judicial, regulatory and other legal or governmental
agencies and bodies (collectively, the “Consents”), to own, lease and operate its properties and
conduct its business as it is now being conducted and as disclosed in the Registration Statement,
the Pricing Disclosure Package and the Prospectus. No Consent contains a materially burdensome
restriction not adequately disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus.
(l) The Company has the requisite corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated by
this Agreement, the Registration Statement, the Pricing Disclosure Package and the Prospectus.
This Agreement and the transactions contemplated by this Agreement have been duly and validly
authorized by the Company. This Agreement has been duly and validly executed and delivered by the
Company.
(m) The execution, delivery, and performance by the Company of this Agreement and the Capped
Call Agreements and the consummation of the transactions contemplated by herein and therein do not
and will not (i) conflict with, require consent under or result in a breach of any of the terms and
provisions of, or constitute a default (or an event which with notice or lapse of time, or both,
would constitute a default) under, or result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any Subsidiary pursuant to, any
indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, franchise,
license or permit to which the Company or any Subsidiary is a
7
party or by which the Company or any Subsidiary or their respective properties, operations or
assets may be bound, (ii) violate or conflict with any provision of the certificate or articles of
incorporation, by-laws, certificate of formation, limited liability company agreement, partnership
agreement or other organizational documents of the Company or any Subsidiary, or (iii) violate or
conflict with any law, rule, regulation, ordinance, directive, judgment, decree or order of any
judicial, regulatory or other legal or governmental agency or body, domestic or foreign, except (in
the case of clauses (i) and (iii) above) as could not reasonably be expected to have a Material
Adverse Effect.
(n) No Consent of, with or from any judicial, regulatory or other legal or governmental agency
or body or any third party, foreign or domestic, is required for the execution, delivery and
performance of this Agreement, the Capped Call Agreements or the consummation of the transactions
contemplated herein or therein, except the registration under the Securities Act of the Shares,
which is in full force and effect, and such Consents as may be required under state or foreign
securities or blue sky laws or the by-laws and rules of the Financial Industry Regulatory Authority
(“FINRA”) in connection with the purchase and distribution of the Shares by the Underwriters.
(o) Except as disclosed in the Pricing Disclosure Package, there is no legal or governmental
proceeding to which the Company or any Subsidiary is a party or of which any property, operations
or assets of the Company or any Subsidiary is the subject which, individually or in the aggregate,
if determined adversely to the Company or any Subsidiary, could reasonably be expected to have a
Material Adverse Effect; to the Company’s knowledge, no such proceeding is threatened or
contemplated.
(p) The financial statements, including the notes thereto, included or incorporated by
reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus present
fairly, in all material respects, the financial position as of the dates indicated and the cash
flows and results of operations for the periods specified of the Company and its consolidated
subsidiaries; and except as otherwise stated in the Pricing Disclosure Package, said financial
statements have been prepared in conformity with United States generally accepted accounting
principles applied on a consistent basis throughout the periods involved. The other financial and
statistical information included or incorporated by reference in the Registration Statement, the
Pricing Disclosure Package and the Prospectus are correct and accurate in all material respects
and, with respect to such financial information, have been prepared on a basis consistent with that
of the financial statements that are included or incorporated by reference in the Registration
Statement, the Pricing Disclosure Package and the Prospectus from which such information has been
derived.
(q) The Company is subject to the reporting requirements of Section 13 or 15(d) of the
Exchange Act and files reports with the Commission on XXXXX. The Common Stock is registered
pursuant to Section 12(b) of the Exchange Act and the outstanding shares of Common Stock are listed
on the New York Stock Exchange (the “NYSE”) and the Company has taken no action designed to, or
likely to have the effect of, terminating the registration of the Common Stock under the Exchange
Act or de-listing the Common Stock from the NYSE, nor has the Company received any notification
that the Commission or the NYSE is contemplating terminating such registration or listing.
8
(r) The documents incorporated or deemed to be incorporated by reference into the Registration
Statement, the Pricing Disclosure Package and the Prospectus at the time they were filed with the
Commission, complied in all material respects with the requirements of the Exchange Act and the
rules and regulations thereunder.
(s) The Company and its Subsidiaries maintain a system of internal accounting and other
controls sufficient to provide reasonable assurances that (i) transactions are executed in
accordance with management’s general or specific authorizations, (ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with United States generally
accepted accounting principles and to maintain accountability for assets, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization, and (iv) the
recorded accounting for assets is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences.
(t) Neither the Company nor any of its affiliates (within the meaning of Rule 144 under the
Securities Act) has taken, directly or indirectly, any action which constitutes or is designed to
cause or result in, or which could reasonably be expected to constitute, cause or result in, the
stabilization or manipulation of the price of any security to facilitate the sale or resale of the
Shares.
(u) The Company is not and, at all times up to and including the consummation of the
transactions contemplated by this Agreement, the Capped Call Agreements and the Pricing Disclosure
Package and at all times during the Offering Period, will not be, required to register as an
“investment company” under the Investment Company Act of 1940, as amended, and is not and will not
be an entity “controlled” by an “investment company” within the meaning of such act.
(v) No relationship, direct or indirect, exists between or among the Company or any affiliate
of the Company, on the one hand, and any director, officer, stockholder, customer or supplier of
the Company or any affiliate of the Company, on the other hand, which is required by the Exchange
Act to be described in the Company’s annual and/or quarterly reports on Form 10-K and 10-Q, as
applicable, which is not so described and described as required in such reports. There are no
outstanding loans, advances (except normal advances for business expenses in the ordinary course of
business) or guarantees of indebtedness by the Company to or for the benefit of any of the officers
or directors of the Company or any of their respective family members. The Company has not, in
violation of the Xxxxxxxx-Xxxxx Act, directly or indirectly, including through a Subsidiary,
extended or maintained credit, arranged for the extension of credit, or renewed an extension of
credit, in the form of a personal loan to or for any director or executive officer of the Company.
(w) Except as otherwise set forth in the Pricing Disclosure Package, and except for (i) the
usual and customary liens in favor of the operator under applicable operating agreements, (ii)
mechanic’s and materialman’s liens that are not delinquent or are being disputed in good faith,
(iii) liens of the various taxing authorities for ad valorem property taxes that are not yet due,
or if due, are not delinquent, and (iv) such other liens, encumbrances and defects that,
individually or in the aggregate, would not materially affect the value thereof or materially
interfere with the use made or to be made thereof by them, the Company and its Subsidiaries
9
have title to the properties described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus as being owned by them as follows: (A) with respect to producing
properties (including oil and gas xxxxx, producing leasehold interests and appurtenant personal
property), such title is good and Defensible (as defined below) and free and clear of all Liens;
(B) with respect to their respective non-producing leasehold properties (including undeveloped
locations on leases held by production and those leases not held by production and including
exploration prospects described in the Registration Statement, the Pricing Disclosure Package and
the Prospectus as being owned by them), such title was investigated in accordance with customary
industry procedures prior to the Company’s acquisition thereof; (C) with respect to their
respective real property other than oil and gas interests described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus as being owned by them, such title is good and
indefeasible and free and clear of all Liens; and (D) with respect to their respective personal
property other than that appurtenant to its oil and gas interests, such title is free and clear of
all liens, security interests, pledges, charges, encumbrances, mortgages and restrictions. As used
herein, “Defensible” means, with respect to title to the producing properties (including oil and
gas xxxxx and producing leasehold interests) described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus as being owned by the Company and its Subsidiaries, that the
Company and its Subsidiaries (i) are entitled to receive not less than the net revenue interests of
such properties as set forth in the reserve report of Netherland Xxxxxx dated as of June 30, 2007
(the “Netherland Xxxxxx Report”) of all hydrocarbons and minerals produced, saved and marketed from
such properties, and proceeds thereof, all without reduction, suspension or termination of such
interests throughout the productive life of such properties, and (ii) are obligated to bear a share
of the costs and expenses relating to the maintenance, exploration, drilling, completion,
development, operation, plugging and abandonment of such properties not greater than the working
interests of such properties as set forth in the Netherland Xxxxxx Report, without increase
throughout the life of such properties.
(x) The Company and each Subsidiary (i) owns or possesses adequate right to use all patents,
patent applications, trademarks, service marks, trade names, trademark registrations, service xxxx
registrations, copyrights, licenses, formulae, customer lists, and know-how and other intellectual
property (including trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures) necessary for the conduct of their respective
businesses as being conducted and as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus and (ii) have no reason to believe that the conduct of their
respective businesses does or will conflict with, and have not received any notice of any claim of
conflict with, any such right of others.
(y) The Company and the Subsidiaries maintain insurance in such amounts and covering such
risks as the Company reasonably considers adequate for the conduct of its business and the value of
its properties and as is customary for companies engaged in similar businesses in similar
industries, all of which insurance is in full force and effect, except where the failure to
maintain such insurance could not reasonably be expected to have a Material Adverse Effect. There
are no material claims by the Company or any Subsidiary under any such policy or instrument as to
which any insurance company is denying liability or defending under a reservation of rights clause.
The Company reasonably believes that it will be able to renew its existing insurance as and when
such coverage expires or will be able to obtain replacement
10
insurance adequate for the conduct of the business and the value of its properties at a cost
that could not reasonably be expected to have a Material Adverse Effect.
(z) Each of the Company and the Subsidiaries has accurately prepared and timely filed all
federal, state, foreign and other tax returns that are required to be filed by it and has paid or
made provision for the payment of all taxes, assessments, governmental or other similar charges,
including without limitation, all sales and use taxes and all taxes which the Company or any
Subsidiary is obligated to withhold from amounts owing to employees, creditors and third parties,
with respect to the periods covered by such tax returns (whether or not such amounts are shown as
due on any tax return), except where the failure to file or pay could not reasonably be expected to
have a Material Adverse Effect. No deficiency assessment with respect to a proposed adjustment of
the Company’s or any Subsidiary’s federal, state, local or foreign taxes is pending or, to the best
of the Company’s knowledge, threatened, except where such assessment could not reasonably be
expected to have a Material Adverse Effect. The accruals and reserves on the books and records of
the Company and the Subsidiaries in respect of tax liabilities for any taxable period not finally
determined are adequate to meet any assessments and related liabilities for any such period in all
material respects and, since December 31, 2006, the Company and the Subsidiaries have not incurred
any liability for taxes other than in the ordinary course of its business. There is no tax lien,
whether imposed by any federal, state, foreign or other taxing authority, outstanding against the
assets, properties or business of the Company or any Subsidiary.
(aa) No labor disturbance by the employees of the Company or any Subsidiary exists or, to the
best of the Company’s knowledge, is imminent and the Company is not aware of any existing or
imminent labor disturbances by the employees of any of its or any Subsidiary’s principal suppliers,
manufacturers’, customers or contractors, which, in either case (individually or in the aggregate),
could reasonably be expected to have a Material Adverse Effect.
(bb) No “prohibited transaction” (as defined in either Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published interpretations
thereunder (“ERISA”) or Section 4975 of the Internal Revenue Code of 1986, as amended from time to
time (the “Code”)), “accumulated funding deficiency” (as defined in Section 302 of ERISA) or other
event of the kind described in Section 4043(b) of ERISA (other than events with respect to which
the 30-day notice requirement under Section 4043 of ERISA has been waived) has occurred with
respect to any employee benefit plan for which the Company or any Subsidiary would have any
liability; each employee benefit plan for which the Company or any Subsidiary would have any
liability is in compliance in all material respects with applicable law, including (without
limitation) ERISA and the Code; the Company has not incurred and does not expect to incur liability
under Title IV of ERISA with respect to the termination of, or withdrawal from any “pension plan”;
and each plan for which the Company would have any liability that is intended to be qualified under
Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or by
failure to act, which could cause the loss of such qualification.
(cc) There has been no storage, generation, transportation, handling, treatment, disposal,
discharge, emission or other release of any kind of toxic or other wastes or
11
other hazardous substances by, due to, or caused by the Company or any Subsidiary (or, to the
Company’s knowledge, any other entity for whose acts or omissions the Company is or may be liable)
upon any other property now or previously owned or leased by the Company or any Subsidiary, or upon
any other property, which would be a violation of or give rise to any liability under any
applicable law, rule, regulation, order, judgment, decree or permit relating to pollution or
protection of human health (to the extent relating to exposure to toxic or other wastes or other
hazardous substances) and the environment (“Environmental Law”), except for any violation or
liability which could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect. There has been no disposal discharge, emission or other release of any
kind onto such property or into the environment surrounding such property of any toxic or other
wastes or other hazardous substances, except as could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary
has agreed to assume, undertake or provide indemnification for any liability of any other person
under any Environmental Law, including any obligation for cleanup or remedial action. There is no
pending or, to the best of the Company’s knowledge, threatened administrative, regulatory or
judicial action, claim or notice of noncompliance or violation, investigation or proceedings
relating to any Environmental Law against the Company or any Subsidiary, except where such action,
claim, notice or violation could not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect.
(dd) Neither the Company, any Subsidiary nor, to the Company’s knowledge, any of its employees
or agents has at any time during the last five years (i) made any unlawful contribution to any
candidate for foreign office, or failed to disclose fully any contribution in violation of law, or
(ii) made any payment to any federal or state governmental officer or official, or other person
charged with similar public or quasi-public duties, other than payments required or permitted by
the laws of the United States of any jurisdiction thereof.
(ee) Neither the Company nor any Subsidiary (i) is in violation of its certificate or articles
of incorporation, by-laws, certificate of formation, limited liability company agreement,
partnership agreement or other organizational documents, (ii) is in default under, and no event has
occurred which, with notice or lapse of time or both, would constitute a default under or result in
the creation or imposition of any lien, charge or encumbrance upon any property or assets of the
Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which it is a party or by which it is bound or to
which any of its property or assets is subject or (iii) is in violation in any respect of any law,
rule, regulation, ordinance, directive, judgment, decree or order of any court or governmental or
regulatory agency or body, except (in the case of clauses (ii) and (iii) above) violations or
defaults that could not reasonably be expected to have a Material Adverse Effect and except (in the
case of clause (ii) alone) for any lien, charge or encumbrance disclosed in the Pricing Disclosure
Package.
(ff) The Company has complied with the requirements of Rule 433 under the Securities Act with
respect to each Issuer Free Writing Prospectus including, without limitation, all prospectus
delivery, filing, record retention and legending requirements applicable to any such Issuer Free
Writing Prospectus. The Company has not (i) distributed any offering material in connection with
the Offering other than the Pricing Prospectus, the Prospectus and any Issuer Free Writing
Prospectus set forth on Annex III hereto, or (ii) filed, referred to,
12
approved, used or authorized the use of any “free writing prospectus” as defined in Rule 405
under the Securities Act with respect to the Offering or the Shares, except for any Issuer Free
Writing Prospectus set forth in Annex III hereto and any electronic road show previously approved
by the Underwriters.
(gg) The Company has established and maintains required “disclosure controls and procedures”
(as defined in Rules 13a-14(c) and 15d-14(c) of the Exchange Act). The Company’s “disclosure
controls and procedures” are reasonably designed to ensure that all information (both financial and
non-financial) required to be disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the Exchange Act, and that all such information is accumulated and communicated to the
Company’s management as appropriate to allow timely decisions regarding required disclosure and to
make the certifications of the Chief Executive Officer and Chief Financial Officer of the Company
required under the Exchange Act with respect to such reports.
(hh) The Registration Statement, the Pricing Disclosure Package and Prospectus comply, and any
further amendments or supplements thereto will comply, with all applicable laws, rules,
regulations, ordinances, directives, judgments, decrees and orders of foreign jurisdictions in
which Directed Shares are offered and the Pricing Disclosure Package and the Prospectus, as amended
or supplemented, if applicable, may be distributed in connection therewith; and no consent of, from
or with any judicial, regulatory or other legal or governmental agency or body, other than such as
have been obtained, is necessary under any such law, rule, regulation, ordinance, directive,
judgment, decree or order.
(ii) The Company has not offered, or caused the Underwriters to offer, Directed Shares to any
person with the intention of unlawfully influencing (i) a customer or supplier of the Company or
any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company or
any Subsidiary or (ii) a trade journalist or publication to write or publish favorable information
about the Company, any Subsidiary or its products.
Any certificate signed by or on behalf of the Company and delivered to the Underwriters or to
counsel for the Underwriters shall be deemed to be a representation and warranty by the Company to
the Underwriters as to the matters covered thereby.
2. Purchase, Sale and Delivery of the Shares.
(a) On the basis of the representations, warranties, covenants and agreements contained
herein, but subject to the terms and conditions set forth herein and therein:
(i) the Company agrees to sell to each Underwriter the number of the Distribution Shares and
Hedge Shares set forth opposite their respective names on Schedule I hereto at a purchase price per
share of $22.56 in case of the Distribution Shares, and at a purchase price per share of $23.03, in
case of the Hedge Shares; provided, however, that the obligation of the Company to sell the Hedge
Shares to each Hedge Seller is conditioned on the Hedge Sellers, collectively, purchasing all of
the Hedge Shares.
13
(ii) each Underwriter, severally and not jointly, agrees to purchase from the Company, at a
purchase price per share of $22.56, the number of the Distribution Shares set forth opposite their
respective names on Schedule I hereto; and
(iii) the Hedge Sellers, severally and not jointly, agree to use best efforts to purchase from
the Company, at a purchase price per share of $23.03, the number of the Hedge Shares set forth
opposite its name on Schedule I hereto.
(b) Payment of the purchase price for, and delivery of the Shares shall be made at 10:00 a.m.,
New York City time, on December 10, 2007, or at such time on such later date not more than three
Business Days after the foregoing date as the Lead Managers shall designate, which date and time
may be postponed by agreement between the Lead Managers and the Company or as provided in Section
10 hereof (such date and time of delivery and payment for the
Shares being herein called the “Closing Date”).
(c) In addition, on the basis of the representations, warranties, covenants and agreements
herein contained, but subject to the terms and conditions herein set forth, the Company hereby
grants to the Underwriters (other than the Hedge Sellers), acting severally and not jointly, the
option to purchase up to 630,750 Additional Distribution Shares at the same purchase price per
share to be paid by the Underwriters for the Distribution Shares as set forth in Section 2(a)
above, for the sole purpose of covering over-allotments in the sale of Distribution Shares by the
Underwriters. This option may be exercised at any time and from time to time, in whole or in part
on one or more occasions, on or before the thirtieth day following the date of the Prospectus, by
written notice from the Lead Managers to the Company. Such notice shall set forth the aggregate
number of Additional Distribution Shares as to which the option is being exercised and the date, as
reasonably determined by the Lead Managers, when the Additional Distribution Shares are to be
delivered (any such date being herein sometimes referred to as the “Additional Closing Date”);
provided, however, that no Additional Closing Date shall occur earlier than the Closing Date or
earlier than the second full business day after the date on which the option shall have been
exercised nor later than the eighth full business day after the date on which the option shall have
been exercised (unless such time and date are postponed in accordance with the provisions of
Section 10 hereof). Upon any exercise of the option as to all or
any portion of the Additional Distribution Shares, each Underwriter (other than the Hedge Sellers),
acting severally and not jointly, agrees to purchase from the Company the number of Additional
Distribution Shares that bears the same proportion to the aggregate number of Additional
Distribution Shares in such notice as the number of Distribution Shares set forth opposite the name
of such Underwriter in Schedule I hereto (or such number increased as set forth in Section 10
hereof) bears to the aggregate number of Distribution Shares issued and
sold hereunder (subject to such adjustments to eliminate fractional shares as the Lead Managers in
their sole discretion shall make).
(d) Payment of the purchase price for, and delivery of the Additional Shares shall be made at
10:00 a.m., New York City time, on the Additional Closing Date, or at such time on such later date
not more than three Business Days after the foregoing date as the Lead Managers shall designate,
which date and time may be postponed by agreement between the Lead Managers and the Company or as
provided in Section 10 hereof.
14
(e) The Company acknowledges and agrees that (i) the terms of this Agreement and the Offering
were negotiated at arm’s length between sophisticated parties represented by counsel, (ii) no
fiduciary, advisory or agency relationship between the Company and the Underwriters has been
created as a result of any of the transactions contemplated by this Agreement or the process
leading to such transactions, irrespective of whether the Underwriters have advised or is advising
any such party on other matters, (iii) the Underwriters’ obligations to the Company in respect of
the Offering are set forth in this Agreement in their entirety and (iv) it has obtained such legal,
tax, accounting and other advice as it deems appropriate with respect to this Agreement and the
transactions contemplated hereby and any other activities undertaken in connection therewith, and
it is not relying on the Underwriters with respect to any such matters.
3. Offering by Underwriters. Upon authorization of the release of the Distribution
Shares by the Lead Managers, the Underwriters propose to offer the Shares for sale to the public
upon the terms and conditions set forth in the Prospectus.
4. Covenants of the Company.
(a) In addition to the other covenants and agreements of the Company contained herein, the
Company further covenants and agrees with the Underwriters that:
(i) The Company shall prepare the Prospectus in a form approved by the Lead Managers and file
such Prospectus pursuant to, and within the time period specified in, Rule 424(b) and Rule 430A or
430C under the Securities Act; prior to the termination of the Offering Period, the Company shall
file no further amendment to the Registration Statement or amendment or supplement to the
Prospectus to which the Lead Managers shall reasonably object in writing after being furnished in
advance a copy thereof and given a reasonable opportunity to review and comment thereon; the
Company shall notify the Lead Managers promptly (and, if requested by the Lead Managers, confirm
such notice in writing) (A) when the Registration Statement and any amendments thereto become
effective, (B) of any request by the Commission for any amendment of or supplement to the
Registration Statement or the Prospectus or for any additional information, (C) of the Company’s
intention to file, or prepare any supplement or amendment to, the Registration Statement relating
to the Shares, any Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus
prior to termination of the Offering Period, (D) of the mailing or the delivery to the Commission
prior to termination of the Offering Period for filing of any amendment of or supplement to the
Registration Statement or the Prospectus, including but not limited to Rule 462(b) under the
Securities Act, (E) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or any post-effective amendment thereto, or suspending
the use of any Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus or, in
each case, of the initiation or threatening of any proceedings therefore, (F) of the receipt of any
comments from the Commission, and (G) of the receipt by the Company of any notification with
respect to the suspension of the qualification of the Shares for sale in any jurisdiction or the
initiation or threatening of any proceeding for that purpose. If the Commission shall propose or
enter a stop order at any time, the Company will use its best efforts to prevent the issuance of
any such stop order and, if issued, to obtain the lifting of such order as soon as possible.
15
(ii) If, at any time when a prospectus relating to the Shares (or, in lieu thereof, the notice
referred to in Rule 173(a) under the Securities Act) is required to be delivered under the
Securities Act or at any time during the Offering Period, any event shall have occurred as a result
of which the Pricing Disclosure Package (prior to the availability of the Prospectus) or the
Prospectus as then amended or supplemented would, in the judgment of the Lead Managers or the
Company, include an untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances
existing at the time of delivery of such Pricing Disclosure Package or Prospectus (or, in lieu
thereof, the notice referred to in Rule 173(a) under the Securities Act) to the purchaser, not
misleading, or if to comply with the Securities Act, the Exchange Act or the Rules and Regulations
it shall be necessary at any time to amend or supplement the Pricing Disclosure Package, the
Prospectus or the Registration Statement, or to file any document incorporated by reference in the
Registration Statement or the Prospectus or in any amendment thereof or supplement thereto, the
Company will notify the Lead Managers promptly and prepare and file with the Commission an
appropriate amendment or supplement or document (in form and substance reasonably satisfactory to
the Lead Managers) that will correct such statement or omission or effect such compliance, and will
use its best efforts to have any amendment to the Registration Statement declared effective as soon
as possible; provided, however, that at any time during the Offering Period, following the sale of
the Distribution Shares, the Company may delay the preparation and filing of such correcting
amendments, supplements or documents for such time as, in the reasonable judgment of the Company,
it would not be in the best interests of the Company to prepare and file such correcting
amendments, supplements or documents; provided further that the Company shall promptly notify the
Lead Managers of any such delay and such delay shall extend the Offering Period by the number of
Exchange Business Days equal to the number of Exchange Business Days in any Suspension Period.
(iii) The Company will not, without the prior consent of the Lead Managers, (A) make any offer
relating to the Shares that would constitute a “free writing prospectus” as defined in Rule 405
under the Securities Act, except for any Issuer Free Writing Prospectus set forth in Annex III
hereto and any electronic road show previously approved by the Underwriters, or (B) file, refer to,
approve, use or authorize the use of any “free writing prospectus” as defined in Rule 405 under the
Securities Act with respect to the Shares. If at any time any event shall have occurred as a
result of which any Issuer Free Writing Prospectus as then amended or supplemented would, in the
judgment of the Underwriters or the Company, conflict with the information in the Registration
Statement, the Pricing Disclosure Package or the Prospectus as then amended or supplemented or
would, in the judgment of the Underwriters or the Company, include an untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances existing at the time of delivery to the
purchaser, not misleading, or if to comply with the Securities Act or the Rules and Regulations it
shall be necessary at any time to amend or supplement any Issuer Free Writing Prospectus, the
Company will notify the Underwriters promptly and, if requested by the Lead Managers, prepare and
furnish without charge to the Underwriters an appropriate amendment or supplement (in form and
substance satisfactory to the Lead Managers) that will correct such statement, omission or conflict
or effect such compliance.
(iv) The Company will comply with the requirements of Rule 433 with respect to each Issuer
Free Writing Prospectus including, without limitation, all
16
prospectus delivery, filing, record retention and legending requirements applicable to each
such Issuer Free Writing Prospectus.
(v) The Company will promptly deliver to each of you and Underwriters’ Counsel a signed copy
of the Registration Statement, as initially filed and all amendments thereto, including all
consents and exhibits filed therewith, and will maintain in the Company’s files manually signed
copies of such documents for at least five years after the date of filing. The Company will
promptly deliver to each of the Underwriters such number of copies of any Preliminary Prospectus,
the Prospectus, the Registration Statement, any Issuer Free Writing Prospectus and all amendments
of and supplements to such documents, if any, and all documents incorporated by reference in the
Registration Statement and Prospectus or any amendment thereof or supplement thereto, as you may
reasonably request. On the business day next succeeding the date of the filing of the Prospectus
and from time to time thereafter, the Company will furnish the Underwriters with copies of the
Prospectus in New York City in such quantities and at such times as you may reasonably request.
(vi) The Company will cooperate with the Lead Managers to qualify the Shares for offering and
sale under the securities laws relating to the offering or sale of the Shares of such
jurisdictions, domestic or foreign, as the Lead Managers may designate and to maintain such
qualification in effect for so long as required for the Offering; except that in no event shall the
Company be obligated in connection therewith to qualify as a foreign corporation or to execute a
general consent to service of process in any jurisdiction or to take any other action that would
subject it to general service of process or to taxation in respect of doing business in any
jurisdiction in which it is not otherwise subject.
(vii) The Company will make generally available to its security holders as soon as
practicable, but in any event not later than twelve months after the effective date of the
Registration Statement (as defined in Rule 158(c) under the Securities Act), an earnings statement
of the Company and the Subsidiaries (which need not be audited) complying with Section 11(a) of the
Securities Act and the Rules and Regulations (including, at the option of the Company, Rule 158).
(viii) During the period commencing on the Closing Date and ending on the later of (x) the
date that is three years following the Closing Date, (y) the last date that a prospectus (or, in
lieu thereof, the notice referred to in Rule 173(a) under the Securities Act) is required to be
delivered under the Securities Act in connection with the offer or sale of the Shares, and (z) the
last day of the Offering Period, the Company will, upon written request, furnish to you copies of
all reports or other communications (financial or other) furnished to security holders or from time
to time published or publicly disseminated by the Company, and will deliver to you (i) as soon as
they are available, copies of any reports, financial statements and proxy or information statements
furnished to or filed with the Commission or any national securities exchange on which any class of
securities of the Company is listed; and (ii) such additional information concerning the business
and financial condition of the Company as you may from time to time reasonably request (such
financial information to be on a consolidated basis to the extent the accounts of the Company and
the Subsidiaries are consolidated in reports furnished to its security holders generally or to the
Commission); provided that the Company need not furnish copies of any report, communication or
information filed with XXXXX.
17
(ix) The Company will use its reasonable best efforts to list the Shares on the NYSE.
(x) The Company, during the period when a prospectus (or, in lieu thereof, the notice referred
to in Rule 173(a) under the Securities Act) is required to be delivered under the Securities Act in
connection with the offer or sale of the Shares and during the Offering Period, will file all
reports and other documents required to be filed by the Company with the Commission pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act and the Rules and Regulations within the time
periods required thereby.
(xi) The Company will not take, and will cause its affiliates (within the meaning of Rule 144
under the Securities Act) not to take, directly or indirectly, any action which constitutes or is
designed to cause or result in, or which could reasonably be expected to constitute, cause or
result in, the stabilization or manipulation of the price of any security to facilitate the sale or
resale of the Shares.
(xii) The Company agrees to deliver, or cause to be delivered, to the Lead Managers, during
the period when a prospectus (or, in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act) is required to be delivered under the Securities Act in connection with the offer
or sale of the Shares and during the Offering Period, on each date after the Closing Date on which
the Registration Statement or Prospectus is amended or supplemented and in the judgment of the Lead
Managers it would be reasonable to request a supplemental letter of Netherland Xxxxxx and upon the
request of the Lead Managers supplemental letters of Netherland Xxxxxx in substantially the same
form as those delivered on the Closing Date pursuant to Section 7 hereof.
(xiii) The Company agrees to deliver, or cause to be delivered, to the Lead Managers, during
the period when a prospectus (or, in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act) is required to be delivered under the Securities Act in connection with the offer
or sale of the Shares and during the Offering Period, on each date after the Closing Date on which
the Registration Statement or Prospectus is amended or supplemented and in the judgment of the Lead
Managers it would be reasonable to request a supplemental letter of Xxxxxx & Xxxxxx L.L.P. and the
Xxxxxxxx Law Firm, L.L.C. and upon the request of the Lead Managers, supplemental letters of Xxxxxx
& Xxxxxx L.L.P. and the Xxxxxxxx Law Firm, L.L.C. in substantially the same form as the “cold
comfort” paragraphs contained in the form of legal opinion of those firms attached hereto as Annex
I and Annex II.
(xiv) The Company agrees to deliver, or cause to be delivered, to the Lead Managers, during
the period when a prospectus (or, in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act) is required to be delivered under the Securities Act in connection with the offer
or sale of the Shares and during the Offering Period, on each date after the Closing Date on which
the Registration Statement or Prospectus is amended or supplemented because of new or updated
financial or accounting information and in the judgment of the Lead Managers it would be reasonable
to request an updated comfort letter and upon the request of the Lead Managers, supplemental
letters of KPMG LLP in substantially the same form as those delivered on the Closing Date pursuant
to Section 7 hereof.
18
(xv) The Company agrees to cause the chief executive officer and the general counsel of the
Company to participate in weekly telephonic due diligence sessions with representatives of the
Hedge Sellers and their counsel during the Offering Period.
(xvi) The Company agrees to provide, or cause to be provided, upon the filing of a report with
the Securities and Exchange Commission required to be filed pursuant to the Exchange Act and during
the Offering Period, a certificate of the Chief Executive Officer and Chief Financial Officer of
the Company, dated within one business day of the filing of such report with the Securities and
Exchange Commission, in form and substance satisfactory to you, as to the accuracy of the
representations and warranties of the Company set forth in Section 1 hereof as of the date thereof,
as to the performance by the Company of all of its obligations hereunder to be performed during the
Offering Period, as to the matters set forth in subsection (a) of this Section 7, and as to such
other matters as you may reasonably request.
(xvii) During the period of 90 days from the date of the Prospectus, without the prior
written consent of the Lead Managers the Company (i) will not, directly or indirectly, issue,
offer, sell, agree to issue, offer or sell, solicit offers to purchase, grant any call option,
warrant or other right to purchase, purchase any put option or other right to sell, pledge, borrow
or otherwise dispose of any Relevant Security, or make any announcement of any of the foregoing,
(ii) will not establish or increase any “put equivalent position” or liquidate or decrease any
“call equivalent position” (in each case within the meaning of Section 16 of the Exchange Act and
the rules and regulations promulgated thereunder) with respect to any Relevant Security, and (iii)
will not otherwise enter into any swap, derivative or other transaction or arrangement that
transfers to another, in whole or in part, any economic consequence of ownership of a Relevant
Security, whether or not such transaction is to be settled by delivery of Relevant Securities,
other securities, cash or other consideration; and the Company will obtain an undertaking in
substantially the form of Annex IV hereto of each of its officers and directors not to engage in
any of the aforementioned transactions on their own behalf, other than the sale of Shares as
contemplated by this Agreement and the Company’s issuance of Common Stock upon (i) the conversion
or exchange of convertible or exchangeable securities outstanding on the date hereof; (ii) the
exercise of currently outstanding options; (iii) the exercise of currently outstanding warrants;
and (iv) the grant and exercise of options under, or the issuance and sale of shares pursuant to,
employee stock option plans in effect on the date hereof, each as described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. The Company will not file a
registration statement under the Securities Act in connection with any transaction by the Company
or any person that is prohibited pursuant to the foregoing, except for registration statements on
Form S-8 relating to employee benefit plans or Form S-4 relating to corporate reorganizations or
other transactions under Rule 145.
(b) The Company has complied and will comply with all applicable securities and other
applicable laws, rules and regulations in each foreign jurisdiction in which the Directed Shares
are offered.
5. Covenant of the Underwriters. The Underwriters covenant and agree with the Company
that the Underwriters will not use or refer to any “free writing prospectus” (as defined in Rule
405 under the Securities Act) without the prior written consent of the Company if such
Underwriters’ use of or reference to such “free writing prospectus” would require the
19
Company to file with the Commission any “issuer information” (as defined in Rule 433 under the
Securities Act).
6. Payment of Expenses. Whether or not the transactions contemplated by this
Agreement, the Capped Call Agreements, the Registration Statement, the Pricing Disclosure Package
and the Prospectus are consummated or this Agreement is terminated, the Company hereby agrees to
pay all costs and expenses incident to the performance of its obligations hereunder, including the
following: (i) all expenses in connection with the negotiation, preparation, printing, typing,
reproduction and filing of the Registration Statement, any Preliminary Prospectus, any Issuer Free
Writing Prospectus, the Prospectus and any and all amendments and supplements thereto and the
mailing and delivering of copies thereof to the Underwriters; (ii) the fees, disbursements and
expenses of the Company’s counsel and accountants in connection with the registration of the Shares
under the Securities Act; (iii) the reproduction and delivery of this Agreement, the preliminary
and supplemental “Blue Sky” memoranda and all other agreements or documents reproduced and
delivered in connection with the Offering, (iv) all expenses in connection with the qualification
of the Shares for offering and sale under state or foreign securities or blue sky laws as provided
in Section 4(a)(vi) hereof and any offering of Directed Shares outside the United States, including
the fees and disbursements of counsel for the Underwriters in connection with such qualification
and in connection with any blue sky survey; (v) the filing fees incident to, and the fees and
disbursements of counsel for the Underwriters in connection with, securing any required review by
the FINRA of the terms of the Offering; (vi) all fees and expenses in connection with listing the
Shares on the NYSE; and (vii) all transportation and other expenses of Company representatives and
employees and any other expense of the Company incurred in connection with attending or hosting
meetings with prospective purchasers of the Shares. The Company also will pay or cause to be paid:
(x) the cost of preparing stock certificates representing the Shares; (y) the cost and charges of
any transfer agent or registrar for the Shares; and (z) all other costs and expenses incident to
the performance of its obligations hereunder which are not otherwise specifically provided for in
this Section 6.
7. Conditions of Underwriters’ Obligations. (a) The obligations of the Underwriters
to purchase and pay for the Distribution Shares and the Additional Shares, as provided herein,
shall be subject to the accuracy of the representations and warranties of the Company herein
contained, as of the date hereof and as of the Closing Date (for purposes of this Section 7(a)
“Closing Date” shall refer to the Closing Date for the Distribution Shares and any Additional
Closing Date, if different, for the Additional Shares), to the performance by the Company of all of
its obligations hereunder, and to each of the following additional conditions:
(i) The Prospectus shall have been filed with the Commission in a timely fashion in accordance
with Section 4(a) hereof; no stop order suspending the effectiveness of the Registration Statement
or any post-effective amendment thereto, and no stop order suspending or preventing the use of any
Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus, shall have been
issued by the Commission and no proceedings therefor shall have been initiated or threatened by the
Commission; all requests for additional information on the part of the Commission shall have been
complied with to your reasonable satisfaction; if the Company has elected to rely on Rule 462(b)
under the Securities Act, the Rule 462(b) Registration Statement shall have become effective by
10:00 p.m. (Washington, D.C.
20
time) on the date of this Agreement; and all necessary regulatory or stock exchange approvals shall
have been received.
(ii) At the Closing Date you shall have received the written opinion of Xxxxxx & Xxxxxx
L.L.P., counsel for the Company, dated the Closing Date and addressed to the Underwriters, in form
and substance satisfactory to you, substantially in the form of Annex I hereto.
(iii) At the Closing Date, you shall have received an opinion of counsel in form and substance
satisfactory to the Underwriters and Underwriters’ Counsel, dated the Closing Date, of the Xxxxxxxx
Law Firm, L.L.C., counsel for the Company, addressed to the Underwriters and substantially in the
form of Annex II hereto.
(iv) At the Closing Date, you shall have received the written opinion of Underwriters’
Counsel, dated the Closing Date and addressed to the Underwriters, in form and substance
satisfactory to you, with respect to the issuance and sale of the Shares, the Registration
Statement, the Pricing Disclosure Package, the Prospectus and such other matters as you may
require, and the Company shall have furnished to Underwriters’ Counsel such documents as they may
reasonably request for the purpose of enabling them to pass upon such matters.
(v) At the Closing Date you shall have received a certificate of the Chief Executive Officer
and Chief Financial Officer of the Company, dated the Closing Date, in form and substance
satisfactory to you, as to the accuracy of the representations and warranties of the Company set
forth in Section 1 hereof as of the date hereof and as of the Closing Date, as to the performance
by the Company of all of its obligations hereunder to be performed at or prior to the Closing Date,
as to the matters set forth in subsection (i) of this Section 7(a), and as to such other matters as you may reasonably request.
(vi) At the time this Agreement is executed and at the Closing Date, you shall have received a
comfort letter, from KPMG LLP, independent public accountants for the Company, dated, respectively,
as of the date of this Agreement and as of the Closing Date, addressed to the Underwriters and in
form and substance satisfactory to the Underwriters and Underwriters’ Counsel.
(vii) The Underwriters shall have received letters from Netherland Xxxxxx, an independent
petroleum engineers firm for the Company, dated, respectively, as of the date hereof and as of the
Closing Date, addressed to the Underwriters and in form and substance satisfactory to the
Underwriters and Underwriters’ Counsel, with respect to the estimated quantities of the Company’s
reserves, the future net revenues from those reserves and their present value as set forth in the
Registration Statement, the Pricing Disclosure Package and the Prospectus and such related matters
as the Underwriters shall reasonably request.
(viii) At the Closing Date, the Shares shall have been approved for listing upon notice of
issuance on the NYSE.
21
(ix) The Company shall have furnished the Underwriters and Underwriters’ Counsel with such
other certificates, opinions or other documents as they may have reasonably requested.
(x) You shall have received from each of the Company’s officers and directors listed on
Schedule II hereto a duly executed lock-up agreement in each case substantially in the form
attached hereto as Annex IV.
(b) The obligations of the Hedge Sellers to use best efforts to purchase and pay for the Hedge
Shares, as provided herein, shall be subject to the accuracy of the representations and warranties
of the Company herein contained, as of the date hereof and as of the Closing Date, to the
performance by the Company of all of its obligations hereunder, and to each of the following
additional conditions:
(i) The conditions set forth in clauses (i) through (x) of Section 7(a) hereof; and
(ii) The Company shall have executed and delivered the Capped Call Agreements (in form and
substance satisfactory to the Lead Managers).
8. Indemnification.
(a) The Company shall indemnify and hold harmless (i) each Underwriter, (ii) each person, if
any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act and each affiliate of each Underwriter within the meaning of Rule 405 under
the Securities Act and (iii) the respective officers, directors, partners, employees,
representatives and agents of each Underwriter or any controlling person, from and against any and
all losses, liabilities, claims, damages and expenses whatsoever as incurred (including but not
limited to attorneys’ fees and any and all expenses whatsoever incurred in investigating, preparing
or defending against any investigation or litigation, commenced or threatened, or any claim
whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or
several, to which they or any of them may become subject under the Securities Act, the Exchange Act
or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in
respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue
statement of a material fact contained in the (1) Registration Statement, as originally filed or
any amendment thereof, or in the Pricing Disclosure Package or the Prospectus, or in any supplement
thereto or amendment thereof, or in any Issuer Free Writing Prospectus, or in any “issuer
information” ( as defined in Rule 433(h)(2) under the Securities Act) filed or required to be filed
pursuant to Rule 433(d) under the Securities Act or (2) materials or information provided to
investors, if any, by, or with the written approval of, the Company in connection with the
marketing of the Shares, including any road show or investor presentations made to investors by the
Company (whether in person or electronically) (“Marketing Materials”), (ii) the omission or alleged
omission to state (A) in the Registration Statement, as originally filed or any amendment thereof,
a material fact required to be stated therein or necessary to make the statements therein not
misleading, or, (B) in the Pricing Disclosure Package or the Prospectus, or in any supplement
thereto or amendment thereof, or in any Issuer Free Writing Prospectus, or in any “issuer
information” ( as defined in Rule 433(h)(2) under the
22
Securities Act), or in any Marketing Materials, a material fact necessary in order to make the
statements therein, in the light of circumstances under which they were made, not misleading, or
(iii) any untrue statement or alleged untrue statement of a material fact included in the
supplement or prospectus wrapper material distributed in connection with the reservation and sale
of the Directed Shares or the omission or alleged omission therefrom of a material fact necessary
to make the statements therein, when considered in conjunction with the Prospectus, the Pricing
Disclosure Package or Preliminary Prospectus, not misleading; provided, however, that the Company
will not be liable in any such case to the extent, but only to the extent, that any such loss,
liability, claim, damage or expense arises out of or is based upon any such untrue statement or
alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of any Underwriter
expressly for use therein. The parties acknowledge and agree that such information provided by or
on behalf of any Underwriter consists solely of the material identified in Section 16 hereof. This
indemnity agreement will be in addition to any liability that the Company may otherwise have,
including under this Agreement.
(b) Each Underwriter, severally and not jointly, shall indemnify and hold harmless (i) the
Company, (ii) each person, if any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act and each affiliate of the Company within the
meaning of Rule 405 under the Securities Act, and (iii) the officers, directors, partners,
employees, representatives and agents of the Company, against any losses, liabilities, claims,
damages and expenses whatsoever as incurred (including but not limited to attorneys’ fees and any
and all expenses whatsoever incurred in investigating, preparing or defending against any
investigation or litigation, commenced or threatened, or any claim whatsoever and any and all
amounts paid in settlement of any claim or litigation), joint or several, to which they or any of
them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such
losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or
are based upon any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, the Pricing Disclosure Package or the Prospectus, or in any amendment
thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission
to state therein a material fact necessary in order to make the statements therein, in light of
circumstances under which they were made, not misleading, in each case to the extent, but only to
the extent, that any such loss, liability, claim, damage or expense arises out of or is based upon
any untrue statement or alleged untrue statement or omission or alleged omission made therein in
reliance upon and in conformity with written information furnished to the Company by or on behalf
of any Underwriter through any of the Lead Managers expressly for use therein; provided, however,
that in no case shall any Underwriter be liable or responsible for any amount in excess of the
discounts and commissions received by such Underwriter. The parties acknowledge and agree that
such information provided by or on behalf of any Underwriter through any of the Lead Managers
consists solely of the material identified in Section 16 hereof. This indemnity will be in
addition to any liability that any Underwriter may otherwise have, including under this Agreement.
(c) In connection with the offer and sale of Directed Shares the Company agrees promptly upon
written notice, to indemnify and hold harmless each Underwriter and each person, if any, who
controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act, and each affiliate of any Underwriter within the meaning
23
of Rule 405 under the Securities Act from and against any and all losses, liabilities, claims,
damages and expenses incurred by them as a result of (i) the violation of any applicable laws or
regulations of any foreign jurisdictions where Directed Shares have been offered or (ii) the
failure of any Directed Share Purchaser, who has agreed to purchase Directed Shares, to pay for and
accept delivery of the Directed Shares. Under no circumstances will the Lead Managers or any
Underwriter be liable to the Company or to any Directed Share Purchaser for any action taken or
omitted to be taken in connection with the Directed Shares or any transaction effected with any
Directed Share Purchaser, except to the extent found in a final judgment by a court of competent
jurisdiction (not subject to further appeal) to have resulted primarily and directly from the gross
negligence or willful misconduct of the Lead Managers or such Underwriter, as the case may be.
(d) Promptly after receipt by an indemnified party under subsection (a), (b) or (c) above of
notice of the commencement of any action, such indemnified party shall, if a claim in respect
thereof is to be made against the indemnifying party under such subsection, notify each party
against whom indemnification is to be sought in writing of the commencement thereof (but the
failure so to notify an indemnifying party shall not relieve it from any liability which it may
have under this Section 8 to the extent that it is not materially prejudiced as a result thereof
and in any event shall not relieve it from any liability that such indemnifying party may have
otherwise than on account of the indemnity agreement hereunder). In case any such action is
brought against any indemnified party, and it notifies an indemnifying party of the commencement
thereof, the indemnifying party will be entitled to participate, at its own expense in the defense
of such action, and to the extent it may elect by written notice delivered to the indemnified party
promptly after receiving the aforesaid notice from such indemnified party, to assume the defense
thereof with counsel satisfactory to such indemnified party; provided, however, that counsel to the
indemnifying party shall not (except with the written consent of the indemnified party) also be
counsel to the indemnified party. Notwithstanding the foregoing, the indemnified party or parties
shall have the right to employ its or their own counsel in any such case, but the fees and expenses
of such counsel shall be at the expense of such indemnified party or parties unless (i) the
employment of such counsel shall have been authorized in writing by one of the indemnifying parties
in connection with the defense of such action, (ii) the indemnifying parties shall not have
employed counsel to take charge of the defense of such action within a reasonable time after notice
of commencement of the action, (iii) the indemnifying party does not diligently defend the action
after assumption of the defense, or (iv) such indemnified party or parties shall have reasonably
concluded that there may be defenses available to it or them which are different from or additional
to those available to one or all of the indemnifying parties (in which case the indemnifying party
or parties shall not have the right to direct the defense of such action on behalf of the
indemnified party or parties), in any of which events such fees and expenses of counsel shall be
borne by the indemnifying parties. No indemnifying party shall, without the prior written consent
of the indemnified parties, effect any settlement or compromise of, or consent to the entry of
judgment with respect to, any pending or threatened claim, investigation, action or proceeding in
respect of which indemnity or contribution may be or could have been sought by an indemnified party
under this Section 8 or Section 9 hereof (whether or not the indemnified party is an actual or
potential party thereto), unless (x) such settlement, compromise or judgment (i) includes an
unconditional release of the indemnified party from all liability arising out of such claim,
investigation, action or proceeding and (ii) does not include a statement as to or an admission of
fault, culpability or any failure to act, by or on
24
behalf of the indemnified party, and (y) the indemnifying party confirms in writing its
indemnification obligations hereunder with respect to such settlement, compromise or judgment.
9. Contribution. In order to provide for contribution in circumstances in which the
indemnification provided for in Section 8 is for any reason held to be unavailable from an
indemnifying party or is insufficient to hold harmless a party indemnified thereunder, the Company,
on the one hand, and the Underwriters, on the other hand, shall contribute to the aggregate losses,
liabilities, claims, damages and expenses of the nature contemplated by such indemnification
provision (including any investigation, legal and other expenses incurred in connection with, and
any amount paid in settlement of, any action, suit or proceeding or any claims asserted, but after
deducting in the case of losses, liabilities, claims, damages and expenses suffered by the Company,
any contribution received by the Company from persons, other than the Underwriters, who may also be
liable for contribution, including persons who control the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act and each affiliate of the Company within
the meaning of Rule 405 under the Securities Act) to which the Company and the Underwriters may be
subject, in such proportion as is appropriate to reflect the relative benefits received by the
Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Shares
or, if such allocation is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to above but also the relative fault of the
Company, on the one hand, and the Underwriters, on the other hand, in connection with the
statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as
well as any other relevant equitable considerations. The relative benefits received by the
Company, on the one hand, and the Underwriters, on the other hand, shall be deemed to be in the
same proportion as (i) the total proceeds from the offering of the Shares (net of discounts but
before deducting expenses) received by the Company bear to (ii) the discounts and commissions
received by the Underwriters, respectively. The relative fault of the Company, on the one hand,
and of the Underwriters on the other hand, shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company or the
Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company and the Underwriters agree that it
would not be just and equitable if contribution pursuant to this
Section 9 were determined by pro
rata allocation or by any other method of allocation which does not take into account the equitable
considerations referred to above. The aggregate amount of losses, liabilities, claims, damages and
expenses incurred by an indemnified party and referred to above in
this Section 9 shall be deemed
to include any legal or other expenses reasonably incurred by such indemnified party in
investigating, preparing or defending against any litigation, or any investigation or proceeding by
any judicial, regulatory or other legal or governmental agency or body, commenced or threatened, or
any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged
omission. Notwithstanding the provisions of this Section 9, (i) in no case shall any Underwriter
be required to contribute any amount in excess of the amount by which the discounts and commissions
applicable to the Shares underwritten or purchased by it pursuant to this Agreement exceeds the
amount of any damages which such Underwriter has otherwise been required to pay by reason of any
untrue or alleged untrue statement or omission or alleged omission and (ii) no person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to
25
contribution from any person who was not guilty of such fraudulent misrepresentation. For
purposes of this Section 9, (A) each person, if any, who controls an Underwriter within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act and each affiliate of an
Underwriter within the meaning of Rule 405 under the Securities Act and (B) the respective
officers, directors, partners, employees, representatives and agents of an Underwriter or any
controlling person shall have the same rights to contribution as such Underwriter, and (1) each
person, if any, who controls any Company within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act and each affiliate of the Company within the meaning of Rule 405
under the Securities Act and (2) the officers, directors, employees, representatives and agents of
the Company shall have the same rights to contribution as the Company, subject in each case to
clauses (i) and (ii) of the immediately preceding sentence. Any party entitled to contribution
will, promptly after receipt of notice of commencement of any action, suit or proceeding against
such party in respect of which a claim for contribution may be made against another party or
parties under this Section 9, notify such party or parties from whom contribution may be sought,
but the failure to so notify such party or parties shall not relieve the party or parties from whom
contribution may be sought from any obligation it or they may have
under this Section 9 or
otherwise. No party shall be liable for contribution with respect to any action or claim settled
without its prior written consent, provided that such written consent was not unreasonably
withheld.
10. Underwriter Default.
(a) If any Underwriter or Underwriters shall default in its or their obligation to purchase
Distribution Shares or Additional Distribution Shares hereunder, and if the Distribution Shares or
Additional Distribution Shares with respect to which such default relates (the “Default Shares”) do
not (after giving effect to arrangements, if any, made by the Lead Managers pursuant to subsection
(b) below) exceed in the aggregate 10% of the number of Distribution Shares or Additional
Distribution Shares, each non-defaulting Underwriter, acting severally and not jointly, agrees to
purchase from the Company that number of Default Shares then being purchased as the number of
Distribution Shares set forth opposite the name of such Underwriter on Schedule I hereto bears to
the aggregate number of Distribution Shares set forth opposite the names of the non-defaulting
Underwriters, subject, however, to such adjustments to eliminate fractional shares as the Lead
Managers in their sole discretion shall make.
(b) In the event that the aggregate number of Default Distribution Shares exceeds 10% of the
number of Distribution Shares or Additional Distribution Shares, as the case may be, the Lead
Managers may in their discretion arrange for themselves or for another party or parties (including
any non-defaulting Underwriter or Underwriters who so agree) to purchase the Default Shares on the
terms contained herein. In the event that within five calendar days after such a default the Lead
Managers do not arrange for the purchase of the Default Shares as
provided in this Section 10, this
Agreement or, in the case of a default with respect to the Additional Shares shall thereupon
terminate, without liability on the part of the Company with respect thereto (except in each case
as provided in Sections 6, 8, 9 and 11) or the Underwriters, but
nothing in this Agreement shall relieve a defaulting Underwriter or Underwriters of its or their
liability, if any, to the other Underwriters and the Company for damages occasioned by its or their
default hereunder.
26
(c) In the event any Default Shares are to be purchased by the non-defaulting Underwriters, or
are to be purchased by another party or partiers as aforesaid, the Lead Managers or the Company
shall have the right to postpone the Closing Date or Additional Closing Date, as the case may be,
for a period, not exceeding five business days, in order to effect whatever changes may thereby be
made necessary in the Registration Statement or the Prospectus or in any other documents an
arrangements and the Company agrees to file promptly any amendment or supplement to the
Registration Statement or the Prospectus which, in the opinion of Underwriters’ Counsel, may
thereby be made necessary or advisable. The term “Underwriter” as used in this Agreement shall
include any party substituted under this Section 10 with like effect as if it had originally been
party to this Agreement with respect to such Default Distribution Shares or Default Shares.
11. Survival Clause. The respective representations, warranties, agreements,
covenants, indemnities and other statements of the Company, its officers and the Underwriters set
forth in this Agreement or made by or on behalf of them, respectively, pursuant to this Agreement
shall remain in full force and effect, regardless of (i) any investigation made by or on behalf of
the Company, any of its officers or directors, the Underwriters or any controlling person referred
to in Sections 8 and 9 hereof and (ii) delivery of and payment for the Shares, and shall be binding
upon and shall inure to the benefit of, any successors, assigns, heirs, personal representatives of
the Company, the Underwriter and indemnified parties referred to in
Section 8 hereof. The
respective agreements, covenants, indemnities and other statements set forth in
Sections 5, 6, 7, 8, 9 and 11
hereof shall remain
in full force and effect, regardless of any termination or cancellation of this Agreement.
12. Termination. (a) This Agreement may be terminated in the sole discretion of the
Lead Managers by notice to the Company given in the event that the Company have failed, refused or
been unable to satisfy all conditions on its respective part to be performed or satisfied hereunder
(including, without limitation, the condition to deliver hedge shares other than for a failure by
the Hedge Sellers to satisfy all conditions on their part to be performed or satisfied hereunder)
on or prior to the Closing Date or any Additional Closing Date or if, at or prior to the Closing
Date or any Additional Closing Date:
(i) any domestic or international event or act or occurrence has materially disrupted, or in
the opinion of the Lead Managers will in the immediate future materially disrupt, the market for
the Company’s securities or securities in general;
(ii) trading on the New York Stock Exchange or the Nasdaq Global Market shall have been
suspended or made subject to material limitations, or minimum or maximum prices for trading shall
have been fixed, or maximum ranges for prices for securities shall have been required, on the New
York Stock Exchange or the Nasdaq Global Market, or by order of the Commission or other regulatory
body or governmental authority having jurisdiction;
(iii) trading in the Company’s securities on the New York Stock Exchange shall have been
suspended or made subject to material limitations;
27
(iv) a banking moratorium has been declared by any state or federal authority or if any
material disruption in commercial banking or securities settlement or clearance services shall have
occurred;
(v) (A) there shall have occurred any outbreak or escalation of hostilities or acts of
terrorism involving the United States or there is a declaration of a national emergency or war by
the United States, or (B) there shall have been any other calamity or crisis or any change in
political, financial or economic conditions if the effect of any such event in (A) or (B), in the
judgment of the Underwriter, makes it impracticable or inadvisable to proceed with the offering,
sale and delivery of the Shares, on the terms and in the manner contemplated by the Pricing
Disclosure Package; or
(vi) any debt securities of the Company shall have been downgraded or placed on any “watch
list” for possible downgrading by any “nationally recognized statistical rating organization” as
defined for purposes of Rule 436(g) under the Securities Act.
(b) Subject to
paragraph (c) below, termination of this Agreement pursuant to
this Section 12
shall be without liability of any party to any other party except as
provided in Section 11 hereof.
(c) If this Agreement shall be terminated pursuant to any of the provisions hereof, or if the
sale of the Shares provided for herein is not consummated because any condition to the obligations
of the Underwriters set forth herein is not satisfied, or because of any refusal, inability or
failure on the part of the Company to perform any agreement herein or comply with any provision
hereof, the Company will, subject to demand by the Lead Managers, reimburse the Underwriters for
all out-of-pocket expenses (including the fees and expenses of their counsel), incurred by the
Underwriters in connection herewith.
13. Notices. All communications hereunder shall be in writing and, if sent to the
Underwriter, shall be hand delivered, mailed by first-class mail, couriered by next-day air courier
or telecopied and confirmed in writing to the Underwriters at Bear Xxxxxxx & Co. Inc., 000 Xxxxxxx
Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: Xxxxxxx Parish, Equity Capital Markets, with a copy to
Underwriter’s Counsel at Xxxxx Xxxx & Xxxxxxxx, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000,
Attention: Xxxxxxx X. Xxxxxxxxx, Xx., telecopy (000) 000-0000. If sent to the Company, shall be
delivered, mailed, couriered or telecopied and confirmed in writing, to at the address set forth in
the Prospectus, Attention: Xxxxxx X. Xxxxxxxx, telecopy (000) 000-0000, with a copy to counsel to
the Company at Xxxxxx & Xxxxxx L.L.P., First City Tower, 0000 Xxxxxx Xxxxxx, Xxxxx 0000, Xxxxxxx,
Xxxxx 00000, Attention: Xxxxx X. Xxxxxxxxxxxx, telecopy (000) 000-0000.
14. Successors. This Agreement shall inure to the benefit of and be binding upon the
Underwriters and the Company and their respective successors and legal representatives, and nothing
expressed or mentioned in this Agreement is intended or shall be construed to give any other person
any legal or equitable right, remedy or claim under or in respect of this Agreement, or any
provisions herein contained; this Agreement and all conditions and provisions hereof being intended
to be and being for the sole and exclusive benefit of such
28
persons and for the benefit of no other person except that (i) the indemnities of the Company
contained in Section 8 of this Agreement shall also be for the benefit of any person or persons who
control the Underwriters within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act and (ii) the indemnities of the Underwriters contained in Section 8 of this
Agreement shall also be for the benefit of the directors of the Company, its officers, employees
and agents and any person or persons who controls the Company within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act. No purchaser of Shares from the Underwriters
will be deemed a successor because of such purchase.
15. No Waiver; Modifications in Writing. No failure or delay on the part of the
Company or the Underwriters in exercising any right, power or remedy hereunder shall operate as a
waiver thereof, nor shall any single or partial exercise of any such right, power or remedy
preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
The remedies provided for herein are cumulative and are not exclusive of any remedies that may be
available to the Company or the Underwriters at law or in equity or otherwise. No waiver of or
consent to any departure by the Company or the Underwriters from any provision of this Agreement
shall be effective unless signed in writing by the party entitled to the benefit thereof;
provided that notice of any such waiver shall be given to each party hereto as set forth
below. Except as otherwise provided herein, no amendment, modification or termination of any
provision of this Agreement shall be effective unless signed in writing by or on behalf of the
Company and the Underwriters. Any amendment, supplement or modification of or to any provision of
this Agreement, any waiver of any provision of this Agreement, and any consent to any departure by
the Company or the Underwriters from the terms of any provision of this Agreement shall be
effective only in the specific instance and for the specific purpose for which made or given.
Except where notice is specifically required by this Agreement, no notice to or demand on the
Company in any case shall entitle the Company to any other or further notice or demand in similar
or other circumstances.
16. Information Supplied by the Underwriters. The statements set forth in the first
and second paragraphs under the subheading “Commissions and Discounts,” the final paragraph under
the subheading “Lock-Up Agreements” and the second sentence in the first paragraph under the
subheading “Other Relationships” under the heading “Plan of Distribution” in the Pricing Prospectus
constitute the only information furnished by or on behalf of the Underwriters for purposes of
Sections 1(b), 1(c), 1(d), 8(a) and 8(b) hereof.
17. APPLICABLE LAW. THE VALIDITY AND INTERPRETATION OF THIS AGREEMENT, AND THE TERMS
AND CONDITIONS SET FORTH HEREIN, SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ANY PROVISIONS RELATING TO CONFLICTS OF LAW.
18. Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument.
29
If the foregoing correctly sets forth your understanding, please so indicate in the space
provided below for that purpose, whereupon this letter shall constitute a binding agreement between
us.
Very truly yours, | ||||
XXXXXXXX PETROLEUM CORPORATION |
||||
By: | /s/ Xxxxx X. Xxxxxx | |||
Name: | Xxxxx X. Xxxxxx | |||
Title: | Executive Vice President | |||
Accepted as of the date first above written
BEAR,
XXXXXXX & CO. INC.
on behalf of itself and the other Underwriters named in Schedule I hereto (other than the Hedge Sellers)
on behalf of itself and the other Underwriters named in Schedule I hereto (other than the Hedge Sellers)
By: BEAR, XXXXXXX & CO. INC.
By:
|
/s/ Xxxxxxx Parish | |||
Name: Xxxxxxx Parish | ||||
Title: Senior Managing Director |
BEAR, XXXXXXX & CO. INC.
as an agent for one of its affiliates
as an agent for one of its affiliates
By: BEAR, XXXXXXX & CO. INC.
By:
|
/s/ Xxxxxxx Parish | |||
Name: Xxxxxxx Parish | ||||
Title: Senior Managing Director |
X.X. Xxxxxx Securities Inc.
on behalf of itself and the other Underwriters named in Schedule I hereto (other than the Hedge Sellers)
on behalf of itself and the other Underwriters named in Schedule I hereto (other than the Hedge Sellers)
By: X.X. XXXXXX SECURITIES INC. | ||||
By:
|
/s/ Xxx Xxxxxxx-Xxxxx | |||
Name: Xxx Xxxxxxx-Xxxxx | ||||
Title: Executive Director |
30
X.X. Xxxxxx Securities Inc.,
as an agent for one of its affiliates
as an agent for one of its affiliates
By:
|
X.X. XXXXXX SECURITIES INC. | |||
By:
|
/s/ Xxx Xxxxxxx-Xxxxx | |||
Name: Xxx Xxxxxxx-Xxxxx | ||||
Title: Executive Director |
31
SCHEDULE I
Total Number of | ||||||||||||
Additional | ||||||||||||
Distribution Shares | ||||||||||||
Total Number of | Total Number of | to be Purchased if | ||||||||||
Distribution Shares | Hedge Shares to be | Option is Fully | ||||||||||
Underwriter | to be Purchased | Purchased | Exercised | |||||||||
Bear, Xxxxxxx & Co. Inc. |
1,345,600 | N/A | 201,837 | |||||||||
X.X. Xxxxxx
Securities Inc. |
1,135,350 | N/A | 170,303 | |||||||||
Bear,
Xxxxxxx & Co. Inc., acting as an
agent for one of its
affiliates |
N/A | 725,000 | N/A | |||||||||
X.X. Xxxxxx
Securities Inc., acting as an agent for one of its
affiliates |
N/A | 870,000 | N/A | |||||||||
Xxxxxx Xxxx Incorporated. |
420,500 | N/A | 63,075 | |||||||||
Xxxxxxx
Xxxxx & Associates, Inc. |
420,500 | N/A | 63,075 | |||||||||
Capital Once Southcoast, Inc. |
210,250 | N/A | 31,538 | |||||||||
Xxxxxxx Rice
& Company L.L.C. |
210,250 | N/A | 31,538 | |||||||||
Tudor,
Xxxxxxxxx & Co. Securities, Inc. |
210,250 | N/A | 31,538 | |||||||||
BMO Capital
Markets Corp. |
126,150 | N/A | 18,923 | |||||||||
BNP Paribas
Securities Corp. |
126,150 | N/A | 18,923 |
SCHEDULE II
Directors and Officers of the Company Executing Lock-Up Agreements
1. | Xxxxxx X. Xxxxxxxx | |
2. | Xxxxxxx X. Xxxxxx, III | |
3. | Xxxxxx X. Xxxxxxx, Xx. | |
4. | Xxxx. X. Xxxxxxx | |
5. | Xxxxx X. Xxxxxx | |
6. | Xxxxx Xxxxxxxx | |
7. | Xxxxxx X. Xxxxxx | |
8. | Xxxx X. Xxxxxxxxx | |
9. | Xxxxxxxxx X. Xxxxxxx | |
10. | Xxxxxxx X. Xxxxxx | |
11. | Xxxxxx X. Xxxxxxxxx | |
12. | Xxxx Xxxxxxxxxx |
EXHIBIT A
Subsidiaries of Xxxxxxxx Petroleum Corporation
• | Xxxxxxxx Petroleum Company LLC— organized in the State of Louisiana | ||
• | Xxxxxxxx Petroleum Company—Lafitte, LLC—organized in the State of Louisiana | ||
• | LECE, Inc.—incorporated in the State of Texas |
ANNEX I
Form of Opinion of Xxxxxx & Xxxxxx L.L.P.
1. The Company has been duly incorporated and validly exists as a corporation in good standing
under the laws of the State of Delaware, with requisite corporate power and authority to own its
properties and conduct its business as described in the Pricing Disclosure Package. The Company is
duly qualified to do business and in good standing as a foreign corporation in the State of Texas.
2. The Company has an authorized capital stock as set forth in the Pricing Disclosure Package.
3. The Underwriting Agreement has been duly and validly authorized, executed and delivered by
the Company.
4. The Company has the requisite corporate power and authority to execute and deliver the
Underwriting Agreement and to perform its obligations thereunder.
5. The Shares to be delivered on the Closing Date have been duly authorized and, when issued
and paid for in accordance with the terms of the Underwriting Agreement, will be validly issued,
fully paid and non-assessable and will not have been issued in violation of or subject to
preemptive or, similar rights under the Company’s Restated Certificate of Incorporation or Bylaws
or under the Delaware General Corporation Law that entitle or will entitle any person to acquire
any Common Stock from the Company upon issuance or sale thereof.
6. When the Shares are delivered and paid for in accordance with the terms of the Underwriting
Agreement, such Shares will conform in all material respects to the descriptions thereof contained
in the Pricing Disclosure Package.
7. No consent, approval, authorization, order, registration, filing, qualification, license or
permit of or with any court or any judicial, regulatory or other legal or governmental agency or
body is required for the execution, delivery and performance by the Company of the Underwriting
Agreement, the Capped Call Agreements or the consummation of the transactions contemplated therein,
except for (1) such as may be required under the Exchange Act and state securities or blue sky laws
in connection with the purchase and distribution of the Shares by the Underwriters (as to which
such counsel need express no opinion), (2) such as have been made or obtained under the Securities
Act and (3) such as are required by the FINRA.
8. To such counsel’s knowledge and other than as set forth in the Registration Statement and
the Pricing Disclosure Package, there are no legal or governmental proceedings pending in any
Federal or state court located in the State of Texas that are required to be described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus and that are not
described therein as required.
Annex I — Page 1
9. The execution, delivery, and performance of the Underwriting Agreement and the Capped Call
Agreements by the Company and the consummation by the Company of the transactions contemplated by
the Underwriting Agreement and the Capped Call Agreements, do not and will not (A) conflict with or
result in a breach of any of the terms and provisions of, or constitute a default (or an event
which with notice or lapse of time, or both, would constitute a default) under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or assets of the
Company or any of its Subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan
agreement or any other agreement or instrument to which the Company or any of its Subsidiaries is a
party or by which any of the Company or any of its Subsidiaries or their respective properties or
assets may be bound and which is listed as an exhibit to the Company’s annual report on Form 10-K
for the year ended December 31, 2006 or as an exhibit to any subsequently filed report under the
Exchange Act or (B) violate any provision of the restated certificate of incorporation or by-laws
of the Company or (C) result in the violation of any judgment, decree, or order, known to such
counsel issued by any court or governmental agency or body under any federal or Texas state statute
having jurisdiction over the Company or any of its Subsidiaries or under the Delaware General
Corporations Law (“DGCL”), or of any federal, Delaware or Texas state statute, rule or regulation
known to such counsel or of the DGCL except, with respect to clauses (A) and (C) for such
violations that, in the aggregate, would not have a Material Adverse Effect; provided, however,
that the opinion expressed in clause (C) herein shall not include antifraud provisions of federal
or state securities laws or Blue Sky laws or other antifraud statutes, rules or regulations.
10. The Company is not and, after giving effect to the offering and sale of the Shares and the
application of the proceeds thereof as described in the Pricing Disclosure Package, will not be,
required to register as an “investment company” as such term is defined in the Investment Company
Act of 1940, as amended.
11. The Registration Statement, Pricing Disclosure Package and the Prospectus (other than (a)
the financial statements and schedules and other financial data included or incorporated by
reference therein, or omitted therefrom (b) the other financial information included or
incorporated by reference therein or omitted therefrom and (c) the oil and natural gas reserve data
included or incorporated by reference therein, as to which no opinion need be rendered) appear on
their face be appropriately responsive in all material respects with the requirements of the
Securities Act and the Rules and Regulations.
12. The statements in the Pricing Disclosure Package under the caption “Description of Capital
Stock”, insofar as such statements constitute summaries of the legal matters, documents and
proceedings referred to therein, fairly present in all material respects the information called for
with respect to such legal matters, documents and proceedings.
13. The statements in the Pricing Disclosure Package under the caption “Certain U.S. Federal
Tax Considerations for Non-United States Holders,” insofar as such statements constitute matters of
law or legal conclusions, are correct in all material respects.
14. The Registration Statement was declared effective under the Securities Act on August 22,
2007, and, to the knowledge of such counsel, no stop order suspending the effectiveness of the
Registration Statement or any post-effective amendment thereof has been
Annex I - Page 2
issued and no proceedings therefor have been initiated or threatened by the Commission; the
Prospectus was filed with the Commission pursuant to Rule 424(b) under the Securities Act have been
made in the manner and in the time period required therein.
In addition, such opinion shall also contain a statement that such counsel has participated in
conferences with officers and representatives of the Company, representatives of the independent
public accountants for the Company and the Underwriters at which the contents of the Registration
Statement, the Pricing Disclosure Package and the Prospectus and related matters were discussed
and, although it did not independently verify such information, are not passing upon, and do not
assume any responsibility for and express no opinion regarding the accuracy, completeness or
fairness of the statements contained or incorporated by reference in, the Registration Statement,
the Pricing Disclosure Package and the Prospectus), (except as expressly provided in paragraphs 12
and 13 above), on the basis of the foregoing participation (relying with respect to factual matters
to the extent such counsel deems appropriate upon statements by officers and other representatives
of the Company and the Underwriters) no facts have come to the attention of such counsel that would
cause such counsel to believe that (A) the Registration Statement, at the time it became effective,
contained any untrue statement of a material fact or omitted to state any material fact required to
be stated therein or necessary to make the statements therein not misleading, or (B) the
Prospectus, as of its date and as of the Closing Date, contained or contains an untrue statement of
a material fact or omitted or omits to state any material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading; or (C) the
Pricing Disclosure Package, as of the Applicable Time and as of the Closing Date, contained or
contains an untrue statement of a material fact or omitted or omits to state any material fact
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading (it being understood that such counsel need express no belief or opinion with
respect to the financial statements, including the notes, and schedules thereto and the auditor’s
report thereon and any other financial or accounting data, and the oil and natural gas reserve data
included or incorporated by reference therein or omitted therefrom, the Registration Statement, the
Pricing Disclosure Package or the Prospectus).
Counsel may also state that as to matters with respect to which an opinion is stated to be “to
our knowledge,” “known to us” or words of similar effect, such counsel has not undertaken any
independent examination of the facts or records of any court, tribunal or other governmental or
regulatory body, but have been based upon reliance upon a certificate of an officer of the Company
as to factual matters and upon actual knowledge of attorneys of such counsel who have devoted time
to substantive legal matters for the Company and its Subsidiaries.
Annex I - Page 3
ANNEX II
Form of Opinion of the Xxxxxxxx Law Firm, L.L.C.
1. The Principal Subsidiary has been duly formed and validly exists as a limited liability company
in good standing under the laws of the State of Louisiana, with full power and authority to own its
properties and conduct its business as described in the Pricing Disclosure Package. The Principal
Subsidiary is duly qualified to do business and in good standing as a foreign limited liability
company in the State of Texas. The Company is the sole member of the Principal Subsidiary.
2. To such counsel’s knowledge and other than as set forth in the Pricing Disclosure Package [or as
identified in a schedule to the opinion], there are no legal or governmental proceedings pending or
overtly threatened to which the Company or Principal Subsidiary is a party or to which any property
of the Company or Principal Subsidiary is subject which, if determined adversely to the Company or
any of its Principal Subsidiary, would individually or in the aggregate have a Material Adverse
Effect.
3. The execution, delivery and performance by the Company of the Underwriting Agreement and the
Capped Call Agreements and the consummation of the transactions contemplated by the Underwriting
Agreement, the Capped Call Agreements and the Pricing Disclosure Package will not conflict with or
result in a breach of any of the terms and provisions of, or constitute a default (or an event
which with notice or lapse of time, or both, would constitute a default) under, that certain
Amended and Restated Credit Agreement dated as of November 17, 2005, by and among Xxxxxxxx
Petroleum Company, LLC, BNP Paribas, as the agent, and the lenders party thereto, as amended (the
“Credit Agreement”) except for any such breach or default that has been duly and validly waived by
the lenders party thereto.
4. Nothing has come to such Counsel’s attention that would cause me to believe that (a) the Company
or Principal Subsidiary is in violation of its respective charter or by-laws or articles of
organization and operating agreement, (b) the Company or Principal Subsidiary is in default in the
performance of any obligation, agreement, covenant or condition contained in any indenture, loan
agreement (except that this paragraph shall not apply to the Credit Agreement), mortgage, lease or
other agreement or instrument that is material to the Company or its Principal Subsidiary,
individually or taken as a whole, to which the Company or Principal Subsidiary is a party or by
which the Company or Principal Subsidiary or their respective property is bound, (c) the Company or
Principal Subsidiary has violated any environmental law, any provisions of the Employee Retirement
Income Security Act of 1974, as amended, or any provisions of the Foreign Corrupt Practices Act, or
the rules and regulations promulgated thereunder, except for such violations which, singly or in
the aggregate, would not have a Material Adverse Effect, (d) the Company or Principal Subsidiary
does not have such authorizations of, or has not made all filings with and notices to, all
governmental or regulatory authorities and self-regulatory organizations and all courts and other
tribunals, including, without limitation, under any applicable environmental laws, as are necessary
to own, lease, license and operate its respective properties and to conduct its business, except
where the failure to have any such authorization or
Annex II — Page 1
to make any such filing or notice would not, singly or in the aggregate, have a Material Adverse
Effect.
In rendering such opinion, such counsel may rely as to matters of fact, to the extent it deems
proper, on certificates of an officer of the Company provided that copies of any such statements or
certificates shall be delivered to Underwriters’ Counsel.
Annex II — Page 2
ANNEX III
None
Annex III — Page 1
ANNEX IV
[l], 2007
BEAR, XXXXXXX & CO. INC.
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Equity Capital Markets
000 Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Equity Capital Markets
X.X. XXXXXX SECURITIES INC.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Xxxxxxxx Petroleum Corporation Lock-Up Agreement
Ladies and Gentlemen:
This letter agreement (this “Agreement”) relates to the proposed offering (the “Offering”) by
Xxxxxxxx Petroleum Corporation, a Delaware corporation (the “Company”), of its common stock
(“Common Stock”), par value $0.20 per share.
In order to induce you and the underwriters for which you act as representatives to underwrite
the Offering, the undersigned hereby agrees that, without the prior written consent of Bear,
Xxxxxxx & Co. Inc (“Bear Xxxxxxx”) and X.X. Xxxxxx Securities Inc. (“XX Xxxxxx”), during the
period from the date hereof until ninety (90) days from the date of the final offering memorandum
for the Offering (the “Lock-Up Period”), the undersigned (a) will not, directly or indirectly,
offer, sell, agree to offer or sell, solicit offers to purchase, grant any call option or purchase
any put option with respect to, pledge, borrow or otherwise dispose of any Relevant Security (as
defined below), and (b) will not establish or increase any “put equivalent position” or liquidate
or decrease any “call equivalent position” with respect to any Relevant Security (in each case
within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules
and regulations promulgated thereunder), or otherwise enter into any swap, derivative or other
transaction or arrangement that transfers to another, in whole or in part, any economic consequence
of ownership of a Relevant Security, whether or not such transaction is to be settled by delivery
of Relevant Securities, other securities, cash or other consideration. As used herein “Relevant
Security” means the Common Stock, any other equity security of the Company or any of its
subsidiaries, the Company’s 3.25% Convertible Senior Notes and any other security convertible into,
or exercisable or exchangeable for, any Common Stock or other such equity security.
Such agreement will not prevent (a) the exercise of options to purchase shares of Common Stock
pursuant to employee stock option plans, which options are outstanding on the date hereof;
provided, that no sales shall be permitted
ANNEX
IV — Page 1
pursuant to “cashless” exercises of options; (b) the exercise of warrants that are outstanding
on the date hereof; provided, that no sales shall be permitted pursuant to “cashless” exercises of
warrants; (c) transfers of shares of Common Stock to the Company or sales pursuant to a broker
arrangement in satisfaction of any tax withholding obligation of the undersigned in payment of the
exercise price for any stock option exercised by the undersigned or vesting of restricted stock
issued pursuant to stock plans of the Company; (d) transfers of shares of Common Stock to accounts
that the undersigned controls that results only in a change in the form of the undersigned’s
beneficial ownership of securities without changing the undersigned’s pecuniary interest in the
securities and does not result in the obligation to file a report pursuant to Section 16 of the
Exchange Act; [and] (e) bona fide gifts of shares of Common Stock to immediate family members and
charitable institutions, provided as to clause (e), each resulting transferee of shares of Common
Stock executes and delivers to you an agreement satisfactory to you certifying that such transferee
is bound by the terms of this Agreement and has been in compliance with the terms hereof since the
date first above written as if it had been an original party hereto[; and (f) sales of Common Stock
not otherwise permitted by clauses (a) through (e) of no more than 7,500 shares of Common Stock in
the aggregate]1. Any shares of Common Stock received upon the exercise of options or
warrants granted to the undersigned will also be subject to the terms hereof.
The undersigned hereby authorizes the Company during the Lock-Up Period to cause any transfer
agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on
the stock register and other records relating to, Relevant Securities for which the undersigned is
the record holder and, in the case of Relevant Securities for which the undersigned is the
beneficial but not the record holder, agrees during the Lock-Up Period to cause the record holder
to cause the relevant transfer agent to decline to transfer, and to note stop transfer restrictions
on the stock register and other records relating to, such Relevant Securities. The undersigned
hereby further agrees that, without the prior written consent of Bear, Xxxxxxx and XX Xxxxxx,
during the Lock-up Period the undersigned (x) will not file or participate in the filing with the
Securities and Exchange Commission of any registration statement, or circulate or participate in
the circulation of any preliminary or final prospectus or other disclosure document with respect to
any proposed offering or sale of a Relevant Security and (y) will not exercise any rights the
undersigned may have to require registration with the Securities and Exchange Commission of any
proposed offering or sale of a Relevant Security.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Agreement and that this Agreement
1 | Note: clause (f) is only to be included in the Lock-Up Agreements executed by Xxxxxxxxx X. Xxxxxxx, Xxxxxxx X. Xxxxxx, and Xxxxxx X. Xxxxxxxxx. |
ANNEX
IV — Page 2
constitutes the legal, valid and binding obligation of the undersigned, enforceable in
accordance with its terms. Upon request, the undersigned will execute any additional documents
necessary in connection with enforcement hereof. Any obligations of the undersigned shall be
binding upon the successors and assigns of the undersigned from the date first above written.
This Agreement shall be governed by and construed in accordance with the laws of the State of
New York. Delivery of a signed copy of this letter by facsimile transmission shall be effective as
delivery of the original hereof.
Very truly yours,
By:
Print Name:
ANNEX IV — Page 3